Institute of Translational Equitable Medicine
Often, when people think of health equity, they think of it in terms of access. But achieving health equity and reducing disparities in healthcare must start much earlier. At Pfizer, we’re working diligently to identify and address drivers of health disparities in minority and underserved populations by applying medical, scientific, and translational expertise. This is why we are launching the “Institute of Translational Equitable Medicine” or ITEM.
Видео Institute of Translational Equitable Medicine канала Pfizer
Видео Institute of Translational Equitable Medicine канала Pfizer
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Come Join us at PfizerCome Join us at our La Jolla, CA R&D siteThe Four Phases of Clinical Trials3 Reasons People Join a Clinical TrialThe Facts About ADHD (Attention Deficit Hyperactivity Disorder)Exploring mRNA TechnologyHonoring Hemophilia PatientsVenus Williams on #BreakingTheBiasCelebrating Global Health InnovatorsBe Represented. Join a Clinical TrialPfizer's DNAWoman World Hour with Brenda CooperstonePfizer 2021 Environmental, Social & Governance ReportCOVID-19 Vaccine Clinical Trial Volunteers Share What Being Part of the Trial Meant to ThemWhat to Expect From a Clinical TrialSidi’s Story | In My Words: Life with Ulcerative ColitisOur Ongoing Commitment to Multiple Myeloma PatientsAccelerating Health EquityKnow Your Value Segment: Balancing Work & Family with Pfizer’s Donna & NieshaMoonshot: Incredible Stories Behind the Covid-19 Vaccine. Episode 6: William Barnes